| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.9M | -98.3% |
| Cost of Revenue | $76.9M | -2.9% |
| Gross Profit | $32.5M | -9.6% |
| R&D Expense | $343K | — |
| SG&A Expense | $16.5M | +24.7% |
| Operating Income | $5.0M | -60.9% |
| Pre-tax Income | $2.4M | -80.7% |
| Income Tax | $655K | -69.3% |
| Net Income | $1.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $4.8M | -49.5% |
| Inventory | $27.3M | +5.6% |
| Current Assets | $43.6M | +13.7% |
| Total Assets | $54.9M | +30.9% |
| Current Liabilities | $25.7M | +36.7% |
| Total Liabilities | $33.2M | +20.9% |
| Stockholders' Equity | $21.7M | +49.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.7M | -38.9% |
| Capital Expenditures | $388K | +188.0% |
| Investing Cash Flow | -$226K | -86.4% |
| Financing Cash Flow | $3.0M | +127.3% |
| Free Cash Flow | $6.3M | -41.7% |
| -83.1% |
| EPS (Basic) | $0.04 | -84.6% |
| EPS (Diluted) | $0.04 | -84.6% |